Trial · NCT05640648
Participant flow480
How many started, completed or left each group, period by period.
61 to 80 of 480
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Period 2 (Weeks 9-16) | STARTED | Standard Contact Investigation [Control]: Sequence 1 [2 Health Facilities] | 0 | 0 |
| Period 2 (Weeks 9-16) | STARTED | User-centered Contact Investigation [Intervention]: Sequence 1 [2 Health Facilities] | 0 | 0 |
| Period 2 (Weeks 9-16) | STARTED | Standard Contact Investigation [Control]: Sequence 2 [2 Health Facilities] | 353 | 1 |
| Period 2 (Weeks 9-16) | STARTED | User-centered Contact Investigation [Intervention]: Sequence 2 [2 Health Facilities] | 0 | 0 |
| Period 2 (Weeks 9-16) | STARTED | Standard Contact Investigation [Control]: Sequence 3 [2 Health Facilities] | 167 | 1 |
| Period 2 (Weeks 9-16) | STARTED | User-centered Contact Investigation [Intervention]: Sequence 3 [2 Health Facilities] | 0 | 0 |
| Period 2 (Weeks 9-16) | STARTED | Standard Contact Investigation [Control]: Sequence 4 [2 Health Facilities] | 98 | 1 |
| Period 2 (Weeks 9-16) | STARTED | User-centered Contact Investigation [Intervention]: Sequence 4 [2 Health Facilities] | 0 | 0 |
| Period 2 (Weeks 9-16) | STARTED | Standard Contact Investigation [Control]: Sequence 5 [2 Health Facilities] | 124 | 1 |
| Period 2 (Weeks 9-16) | STARTED | User-centered Contact Investigation [Intervention]: Sequence 5 [2 Health Facilities] | 0 | 0 |
| Period 2 (Weeks 9-16) | STARTED | Standard Contact Investigation [Control]: Sequence 6 [2 Health Facilities] | 266 | 1 |
| Period 2 (Weeks 9-16) | STARTED | User-centered Contact Investigation [Intervention]: Sequence 6 [2 Health Facilities] | 0 | 0 |
| Period 2 (Weeks 9-16) | Index Participants | Standard Contact Investigation [Control]: Sequence 1 [2 Health Facilities] | 0 | 0 |
| Period 2 (Weeks 9-16) | Index Participants | User-centered Contact Investigation [Intervention]: Sequence 1 [2 Health Facilities] | 0 | 0 |
| Period 2 (Weeks 9-16) | Index Participants | Standard Contact Investigation [Control]: Sequence 2 [2 Health Facilities] | 64 | 1 |
| Period 2 (Weeks 9-16) | Index Participants | User-centered Contact Investigation [Intervention]: Sequence 2 [2 Health Facilities] | 0 | 0 |
| Period 2 (Weeks 9-16) | Index Participants | Standard Contact Investigation [Control]: Sequence 3 [2 Health Facilities] | 43 | 1 |
| Period 2 (Weeks 9-16) | Index Participants | User-centered Contact Investigation [Intervention]: Sequence 3 [2 Health Facilities] | 0 | 0 |
| Period 2 (Weeks 9-16) | Index Participants | Standard Contact Investigation [Control]: Sequence 4 [2 Health Facilities] | 30 | 1 |
| Period 2 (Weeks 9-16) | Index Participants | User-centered Contact Investigation [Intervention]: Sequence 4 [2 Health Facilities] | 0 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05640648/flow?page=4